Guidance for Industry: Continuous Marketing Applications: Pilot 2 Scientific Feedback and Interactions During Development of Fast Track Products Under PDUFA
ICR 200402-0910-007
OMB: 0910-0518
Federal Form Document
⚠️ Notice: This information collection may be outdated. More recent filings for OMB 0910-0518 can be found here:
Guidance for Industry:
Continuous Marketing Applications: Pilot 2 Scientific Feedback and
Interactions During Development of Fast Track Products Under
PDUFA
Extension without change of a currently approved collection
FDA shall revise
the guidance to display the OMB control number, expiration date and
the burden statement.
Inventory as of this Action
Requested
Previously Approved
06/30/2007
06/30/2007
06/30/2004
125
0
125
10,000
0
10,000
0
0
0
This guidance discusses how the agency
will implement a pilot program for frequent scientific feedback and
interactions between FDA and applicants during the investigational
phase of certain Fast Track drug and biological products.
Applicants are being asked to apply to participate in the Pilot
program.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.